TY - JOUR
T1 - A structure–activity relationship study of phenyl sesquiterpenoids on efflux inhibition against Staphylococcus aureus
AU - Sun, Zhong-Lin
AU - Liu, Tao
AU - Gibbons, Simon
AU - Mu, Qing
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Sixteen natural acetophenone sesquiterpene derivatives were isolated from Ferula ferulioides and 11 synthetic acetophenone sesquiterpene analogues were evaluated to explore the structure–activity relationships (SARs) on their antibacterial activities against a panel of bacteria including drug-resistant Staphylococcus aureus. The minimum inhibitory concentration (MIC) values of the compounds were in the range of 0.5–128 mg/L. Preliminary SAR studies showed that subtle modifications on both the 2’,4’-dihydroxyphenyl moiety and the side chain reduced their activity against drug-resistant S. aureus. All of the compounds that showed no or only weak direct antibacterial activity were tested for their efflux inhibitory effects, among which four compounds showed significant efflux inhibition against drug-resistant strains. Natural product 14 showed significant inhibitory effects for EtBr efflux in strain SA1199B, which has reduced susceptibility to fluoroquinolones by efflux. Compounds 5, 14 and F-3 moderately inhibited EtBr efflux in the macrolide-resistant strain RN4220 and compound 13 moderately inhibited efflux in an MRSA and effluxing tetracycline-resistant strain.
AB - Sixteen natural acetophenone sesquiterpene derivatives were isolated from Ferula ferulioides and 11 synthetic acetophenone sesquiterpene analogues were evaluated to explore the structure–activity relationships (SARs) on their antibacterial activities against a panel of bacteria including drug-resistant Staphylococcus aureus. The minimum inhibitory concentration (MIC) values of the compounds were in the range of 0.5–128 mg/L. Preliminary SAR studies showed that subtle modifications on both the 2’,4’-dihydroxyphenyl moiety and the side chain reduced their activity against drug-resistant S. aureus. All of the compounds that showed no or only weak direct antibacterial activity were tested for their efflux inhibitory effects, among which four compounds showed significant efflux inhibition against drug-resistant strains. Natural product 14 showed significant inhibitory effects for EtBr efflux in strain SA1199B, which has reduced susceptibility to fluoroquinolones by efflux. Compounds 5, 14 and F-3 moderately inhibited EtBr efflux in the macrolide-resistant strain RN4220 and compound 13 moderately inhibited efflux in an MRSA and effluxing tetracycline-resistant strain.
U2 - 10.1007/s00044-019-02375-9
DO - 10.1007/s00044-019-02375-9
M3 - Article
VL - 28
SP - 1308
EP - 1318
JO - Medicinal Chemistry Research
JF - Medicinal Chemistry Research
SN - 1054-2523
ER -